Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the NirsCure-03A near-infrared light therapy device for Alzheimer's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NirsCure-03A Near-infrared light therapy device

Snippet

Sponsor: Danyang Huichuang Medical Equipment Co., Ltd. | Conditions: Alzheimer s Disease | Phase 3 | Status: RECRUITING